Minulet (Ethinylestradiol, Gestodene)

Ethinylestradiol, the active ingredient in Minulet, is a combined oral contraceptive presented as a tablet for oral use. It is used to prevent pregnancy and to regulate menstrual cycles in women of reproductive age.

GNH USA supplies Minulet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minulet is a combined oral contraceptive that acts on the hormonal regulation of the reproductive system. - Contraception: prevents ovulation and thereby avoids pregnancy. - Menstrual cycle regulation: provides predictable monthly bleeding patterns. - Dysmenorrhea management: reduces menstrual pain and associated symptoms.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional tension‑type headache. - Weight gain: modest fluid retention. - Mood changes: fluctuations in emotional state. - Spotting: irregular light bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung arteries. - Stroke: cerebrovascular accident due to clot. - Myocardial infarction: heart attack risk. - Severe allergic reaction: rash, swelling, breathing difficulty. - Liver tumor: rare hepatic neoplasm.

Before prescribing Minulet, consider the following precautions: - Thrombotic risk assessment: evaluate personal or family history of clotting disorders. - Smoking limitation: avoid use in women who smoke more than 15 cigarettes per day. - Liver disease review: contraindicated in active hepatic disease. - Pregnancy testing: ensure patient is not pregnant before initiation. - Blood pressure monitoring: check for hypertension during therapy. - Store at below 25°C: keep in the original pack, protect from moisture.

Minulet may interact with several medicines that affect its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing antiepileptics (e.g., carbamazepine): reduce contraceptive effect. - Rifampicin: lowers hormone levels, increasing pregnancy risk. - St. John’s wort: herbal inducer that diminishes effectiveness. - Certain antibiotics (e.g., griseofulvin): may decrease hormone concentrations.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): may increase hormone levels. - SSRIs (e.g., fluoxetine): potential for altered metabolism. - Diuretics: may affect fluid balance and blood pressure. - Antihypertensives: monitor for additive blood pressure changes.